Acurx Pharmaceuticals, Inc. (ACXP) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-5.32 | +69.5% |
| 2024 | $-17.45 | -1417.4% |
| 2023 | $-1.15 | -2.7% |
| 2022 | $-1.12 | +24.8% |
| 2021 | $-1.49 | -101.4% |
| 2020 | $-0.74 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-5.32 | +69.5% |
| 2024 | $-17.45 | -1417.4% |
| 2023 | $-1.15 | -2.7% |
| 2022 | $-1.12 | +24.8% |
| 2021 | $-1.49 | -101.4% |
| 2020 | $-0.74 | — |